Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Mangoceuticals, Inc. ( (MGRX) ) has shared an announcement.
On June 2 and June 9, 2025, Mangoceuticals, Inc. saw significant warrant exercises and stock conversions, resulting in the issuance of new common stock shares. Abri Advisors Ltd., Clover Crest Bahamas Ltd., and Indigo Capital LP exercised warrants, while a Series B Convertible Preferred Stock conversion also took place, all under exemptions from registration. Additionally, on June 5, 2025, the company executed an Advance Notice under its Equity Purchase Agreement with Platinum Point Capital, selling 100,000 shares for $193,190, further strengthening its financial position.
More about Mangoceuticals, Inc.
Average Trading Volume: 298,091
Technical Sentiment Signal: Sell
Current Market Cap: $22.51M
See more insights into MGRX stock on TipRanks’ Stock Analysis page.